Skip to Content
Print Share
Learn the benefits of AFib implant devices >

Medications for Cardiovascular Risk Reduction

More

    What is Cardiovascular Risk Reduction:  Cardiovascular disease, or heart disease, is a class of diseases that involve the heart and or its blood vessels. Causes are many with the most common being athersclerosis and hypertension. Cardiovascular disease is the leading cause of death world wide. While it mainly affects older adults early prevention by making lifestyle changes such as diet, exercise and medication have have shown to reduce the risk of complications.

    Medications to treat Cardiovascular Risk Reduction

    The following list of medications are in some way related to, or used in the treatment of this condition.

    Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
    simvastatin X N 2 reviews
    1.0

    Generic name: simvastatin systemic

    Brand names:  Zocor, FloLipid

    Drug class: statins

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

     
    Zocor X N Add review Rate

    Generic name: simvastatin systemic

    Drug class: statins

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    Micardis D N X Add review
    6.0

    Generic name: telmisartan systemic

    Drug class: angiotensin receptor blockers

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    telmisartan D N X Add review
    6.0

    Generic name: telmisartan systemic

    Brand name:  Micardis

    Drug class: angiotensin receptor blockers

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

     
    ramipril D N 2 reviews
    7.0

    Generic name: ramipril systemic

    Brand name:  Altace

    Drug class: Angiotensin Converting Enzyme Inhibitors

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

     
    FloLipid X N Add review Rate

    Generic name: simvastatin systemic

    Drug class: statins

    For consumers: dosage, interactions, side effects

    For professionals: Prescribing Information

     
    Altace D N Add review Rate

    Generic name: ramipril systemic

    Drug class: Angiotensin Converting Enzyme Inhibitors

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    alirocumab N 1 review
    9.0

    Generic name: alirocumab systemic

    Brand name:  Praluent

    Drug class: PCSK9 inhibitors

    For consumers: dosage, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph

     
    empagliflozin C N X Add review Rate

    Generic name: empagliflozin systemic

    Brand name:  Jardiance

    Drug class: SGLT-2 inhibitors

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph

     
    Jardiance C N X Add review Rate

    Generic name: empagliflozin systemic

    Drug class: SGLT-2 inhibitors

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    liraglutide C N X Add review Rate

    Generic name: liraglutide systemic

    Brand name:  Victoza

    Drug class: incretin mimetics

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph

     
    Praluent N 1 review
    9.0

    Generic name: alirocumab systemic

    Drug class: PCSK9 inhibitors

    For consumers: dosage, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    Victoza C N X Add review Rate

    Generic name: liraglutide systemic

    Drug class: incretin mimetics

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     

    Legend

    Off Label This medication may not be approved by the FDA for the treatment of this condition.
    Prescription Only / Over the Counter
    Rx Prescription Only
    OTC Over the Counter
    Rx/OTC Prescription or Over the Counter
    Pregnancy
    A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
    B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
    C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
    D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
    X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
    N FDA has not classified the drug.
    Controlled Substances Act Schedule
    N Is not subject to the Controlled Substances Act.
    1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
    2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
    3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
    4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
    5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
    Alcohol
    X Interacts with Alcohol.

    Browse Drugs by Condition

    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

    Drugs.com Mobile Apps

    The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

    Explore Apps
    Hide